REVA Medical Board Member James Schiro Resigns for Health Reasons
July 24 2014 - 6:34PM
REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") announced
today that James J. Schiro will step down from the Board, effective
immediately, in order to undergo treatment after a diagnosis of
multiple myeloma.
"Jim has been an exemplary board member who made outstanding
contributions to our company," said Robert B. Stockman, Chairman
and CEO. "His deep experience across financial services,
corporate governance, strategic positioning, and his penchant to
understand and ask critical questions about our technologies and
markets together with the seriousness with which he carried out his
responsibilities, have left an indelible mark on our
Board. Our management team and his fellow board members
benefited greatly from Jim's wise counsel and friendship. He and
his family are in our thoughts and we are most thankful for his
years of service."
About REVA
REVA is a development stage medical device company located in
San Diego, California, USA, that is focused on the development,
testing, and eventual commercialization of its proprietary
bioresorbable stent products, which are also called "scaffolds."
The Company's technologies combine its stent designs with its
proprietary polymer; these products are designed to offer full
x-ray visibility, clinically relevant sizing, and a controlled and
safe resorption rate. The Company has several products in clinical
study phase. A total of 112 patients were enrolled in its most
recent trial in Australia, Brazil, Europe, and New Zealand; they
will be followed for a total of five years, with primary data to be
obtained at nine and 12 months. REVA will require successful
clinical results and regulatory approval before it can
commercialize any of its products.
CONTACT: United States
Investor and Media Enquiries:
REVA Medical, Inc.
Cheryl Liberatore
Director, Investor Relations and Marketing
+1 858 966-3045
Australia
Investor Enquiries:
Inteq Limited
Kim Jacobs
+61 2 9229 2700
Media Enquiries:
Buchan Consulting
Rebecca Wilson
+61 3 9866 4722
Annabel Murphy
+61 2 9237 2800